VRTX Operating Cash Flow (Statement)

Vertex Pharmaceuticals · Operating Cash Flow (Statement)

VRTX logo

VRTX Operating Cash Flow (Statement)

Latest reported$1.13B
VRTX Quarterly Cash from Operations (-$700.00K → $1.13B)
High-resolution chart · PNG

VRTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
1,125,400,000
1,428,100,000
498,000,000
1,241,400,000
1,073,100,000
818,900,000
584,600,000
1,369,800,000
-3,753,600,000
1,306,600,000
234,600,000
1,268,400,000
1,134,400,000
899,900,000
1,078,400,000
955,500,000
1,139,800,000
956,200,000
994,993,000
927,219,000
-199,767,000
921,055,000
491,532,000
907,748,000
1,038,527,000
815,698,000
446,008,000
334,789,000
463,749,000
324,784,000
314,578,000
381,348,000
321,703,000
252,657,000
227,511,000
170,086,000
181,653,000
265,692,000
144,724,000
65,656,000
40,860,000
-15,137,000
-16,014,000
-47,024,000
-95,213,000
-207,181,000
-121,870,000
-87,647,000
-127,920,000
-175,762,000
28,855,000
-13,720,000
-927,000
-65,778,000
40,559,000
105,961,000
118,405,000
2,916,000
503,663,000
42,895,000
-216,195,000
-186,628,000
-166,103,000
-163,990,000
-108,887,000
-196,462,000
-102,327,000
-21,635,000
-118,065,000
-185,559,000
-97,225,000
-127,480,000
103,758,000
-105,535,000
-52,692,000
-63,641,000
-68,335,000
-67,808,000
-4,287,000
101,502,000
-58,982,000
-60,708,000
-7,003,000
-56,311,000
-53,910,000
-54,830,000
-23,642,000
-43,675,000
-22,971,000
-51,872,000
-28,701,000
-48,532,000
-40,318,000
-50,072,000
-13,476,000
-18,286,000
-17,496,000
-30,281,000
42,257,000
-39,060,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.